| SI No. |
TOPIC |
PDF |
| 01 |
ALPORTS SPECTRUM DISORDER |
DOWNLOAD PDF |
| 02 |
PHEOCHROMOCYTOMA |
DOWNLOAD PDF |
| 03 |
CGM-GUIDED DM IN KIDNEY DISEASE |
DOWNLOAD PDF |
| 04 |
HERPES VIRUS-SHINGRIX |
DOWNLOAD PDF |
| 05 |
ORAL HYPOGLYCEMIA AGENTS (OHA IN CKD) |
DOWNLOAD PDF |
| 06 |
OBESITY AND CKD |
DOWNLOAD PDF |
| 07 |
FUNGAL INFECTION IN POST TRANSPLANT PATIENTS |
DOWNLOAD PDF |
| 08 |
IV IRON AND FGF23 CURRENT EVIDENCE AND FUTURE |
DOWNLOAD PDF |
| 09 |
DAPAGLIFLOZIN (BEYOND GLUCOSE CONTROL-CARDIO-RENAL, METABOLIC PROTECTION. |
DOWNLOAD PDF |
| 10 |
TUBERCULOSIS (TB) IN CKD AND RENAL TRANSPLANT |
DOWNLOAD PDF |
| 11 |
HYPERKALEMIA AND THE RELEVANCE OF CALCIUM POLYSTYRENE SULPHONATE |
DOWNLOAD PDF |
| 12 |
HF Causes Hyperkalemia Prevention and Management |
DOWNLOAD PDF |
| 13 |
Anti GBM Disease |
DOWNLOAD PDF |
| 14 |
Dialysis Access was built by Many Specialities |
DOWNLOAD PDF |
| 15 |
Finereone in Non -Diabetic CKD |
DOWNLOAD PDF |
| 16 |
Lupus Nephritis Flare |
DOWNLOAD PDF |
| 17 |
Recurrence of FSGS in Post Renal Transplantation |
DOWNLOAD PDF |
